Global Internal Beam Radiotherapy/Brachytherapy Market Research Report
- Report Code: IN 1000
- Publish Date: Upcoming
The Global Internal Beam Radiotherapy Market is driven by changing cancer treatment technology and growing number of cancer patients. The market value was estimated to be $471 million in 2013 and expected to reach $532 million by 2018, at a CAGR of 2.50%. The Internal Beam Radiotherapy Market is the second largest segment of $471 million radiotherapy devices market.
The report “Internal Beam Radiotherapy Market Forecast, 2012-2018”, analyzes the market in terms of devices such as Internal Beam Radiotherapy/Brachytherapy are Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy. Types of Internal Beam Radiotherapy/Brachytherapy are low dose rate and high dose rate. All the segments would experience a positive growth till 2018 with an increase in cancer patient pool, increased awareness for procedures, and sophisticated diagnostic techniques. With a market value of $251 million and $197 million, Brachytherapy Seeds, and Applicators & Afterloaders would account for 53% and 42% share in terms of total internal beam radiotherapy devices market. Both the markets have been witnessing maximum growth because of increase in cancer patient pool.
In North America (US, Canada), Europe (Germany, France, Italy, Spain, UK), and Asia (India, China, Japan) the rising rates of cancer population have been driving the market growth. The Internal Beam Radiotherapy market growth is significantly higher in North America because it is always inclined to the newer techniques while comparatively slow-moving markets such as Europe and Japan are maturing with both old and new technologies. North America is the most dynamic, highly competitive and the largest market in the internal beam radiotherapy devices market.
Currently, the seed market is dominating the internal beam radiotherapy market. Internal Beam radiotherapy market holds a minor share in the entire radiotherapy market and it is further shrinking due to non-supportive government reimbursement policy in the U.S. market. After the U.S. market, Europe and BRIC nations are the only potential markets to sustain this therapeutic procedure.
Prevalence of cancer worldwide is around 7.4 million (53%) in males and 6.7 million (47%) in females, with a male and female ratio of 10:9. In 2012, there were an estimated 14.1 million new cases of cancer in the world. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US alone. Cancer remains the second most common cause of death in the US, accounting for nearly one of every four deaths.
The report provides an extensive competitive landscaping of companies operating in this market. The key players of the market covered in this report are ELEKTA AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. The details of segment and country-specific company shares, news and deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies is covered in the report.
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence and patient pool of prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, and lungs cancer, head and neck and esophagus cancer.
- Disease progression (pattern analysis)
Procedure Volume Data
- Number of prostate cancer, gynecology, breast, cervical, and head and neck cancer surgeries performed annually in each country tracked till sub-segment level.
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of radiotherapy devices in various countries.
- Procedural investment in major countries for prostate cancer, gynecology, breast, cervical, and head and neck cancer.
Competitive Intelligence
- The company share analysis of radiotherapy devices for the top players of the market in the region.
- The crucial developments and strategies of companies inculcating in their portfolio for radiotherapy devices.
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Cancer Centers, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Prostate
4.2 Gynecological
4.3 Breast
4.4 Cervical
4.5 Penile
4.6 Lung
4.7 Head and Neck
4.8 Esophagus
5 By Products
5.1 Brachytherapy Seeds
5.2 Applicators & Afterloaders
5.3 Electronic Brachytherapy
6 By Types
6.1 Low Dose Rate
6.2 High Dose Rate
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Global Brachytherapy Seeds Market The Global Brachytherapy Seeds Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $251.4 million in 2013 and expected to be $283.8 million by 2018, growing at a CAGR of 2.5%. The Brachytherapy Seeds Market analyzes the market of devices by segments such as Cesium-131, Iodine-125, Palladium-103, Iridium-192, and Other Seed Market. The prominent players in Brachytherapy Seeds Market globally are Elekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
Applicators & Afterloaders Applicators & Afterloaders and Brachytherapy Seeds and |
Upcoming |
|
|
Electronic Brachytherapy Electronic Brachytherapy and Brachytherapy Seeds and |
Upcoming |
|
|
Cesium-131 Cesium-131 and Iodine-125, Palladium-103 and |
Upcoming |
|
|
Iodine-125 Iodine-125 and Cesium-131, Palladium-103 and |
Upcoming |
|
|
Palladium-103 Palladium-103 and Cesium-131, Iodine-125 and |
Upcoming |
|
|
Iridium-192 Iridium-192 and Cesium-131, Iodine-125 and |
Upcoming |
|
|
North American Internal Beam Radiotherapy/Brachytherapy Market The North American Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $241.7 million in 2013 and expected to be $252.6 million by 2018, growing at a CAGR of 0.9%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Internal Beam Radiotherapy/Brachytherapy are Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
European Internal Beam Radiotherapy/Brachytherapy Market The European Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $123.5 million in 2013 and expected to be $141.1 million by 2018, growing at a CAGR of 2.5%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
Asian Internal Beam Radiotherapy/Brachytherapy Market The Asian Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $68.2 million in 2013 and expected to be $90.6 million by 2018, growing at a CAGR of 5.8%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
North America Brachytherapy Seeds It is segmented on basis of . What makes our report unique? You can request 10% customization in the research matching your exact requirement for e.g. deep dive research in any specific geography or technology or applications.... |
Upcoming |
|
|
North American Brachytherapy Seeds Market The North American Brachytherapy Seeds Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $128.9 million in 2013 and expected to be $134.8 million by 2018, growing at a CAGR of 0.9%. The Brachytherapy Seeds Market analyzes the market of devices by segments such as Cesium-131, Iodine-125, Palladium-103, Iridium-192, and Other Seed Market. The prominent players in Brachytherapy Seeds Market globally are Elekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
European Brachytherapy Seeds Market The European Brachytherapy Seeds Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $68.8 million in 2013 and expected to be $75.2 million by 2018, growing at a CAGR of 1.8%. The Brachytherapy Seeds Market analyzes the market of devices by segments such as Cesium-131, Iodine-125, Palladium-103, Iridium-192, and Other Seed Market. The prominent players in Brachytherapy Seeds Market globally are Elekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
Asian Brachytherapy Seeds Market The Asian Brachytherapy Seeds Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $40 million in 2013 and expected to be $48.3 million by 2018, growing at a CAGR of 3.9%. The Brachytherapy Seeds Market analyzes the market of devices by segments such as Cesium-131, Iodine-125, Palladium-103, Iridium-192, and Other Seed Market. The prominent players in Brachytherapy Seeds Market globally are Elekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
